Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No.157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Eur J Med Res. 2023 May 15;28(1):174. doi: 10.1186/s40001-023-01130-6.
Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD). However, it is unknown whether the ratio of forced vital capacity (FVC) to diffusing lung capacity for carbon monoxide (D) can identify PH in the patients with COPD and predict its prognosis.
The study population I included 937 COPD patients who were admitted to inpatient treatments from 2010 to 2017, and finally 750 patients were available to follow-up the 5-year all-cause mortality (study population II). Clinical characteristics of the study population were recorded.
COPD patients with PH had a higher FVC/D value compared with the patients without PH. The threshold for FVC/D to identify PH in COPD patients was 0.44 l/mmol/min/kPa. Multivariate logistic regression analysis showed that FVC/D was a significant predictor for PH in the patients with COPD. The study population II showed that the 5-year all-cause mortality of COPD patients was significantly higher in combined with PH group than without PH group. Compared with the survivor group, FVC/D value was significantly increased in non-survivor group. The threshold for FVC/D to predict 5-year all-cause mortality was 0.41 l/mmol/min/kPa. Kaplan-Meier survival curves showed that 5-year cumulative survival rate for COPD patients were significantly decreased when the value of FVC/D was ≥ 0.41 l/mmol/min/kPa. Multivariate cox regression analysis showed that FVC/D was an independent prognostic factor for 5-year all-cause mortality in COPD patients.
FVC/D could identify PH in the patients with COPD and was an independent predictor for 5-year all-cause mortality of COPD.
肺动脉高压(PH)是慢性阻塞性肺疾病(COPD)的常见并发症。然而,尚不清楚用力肺活量(FVC)与一氧化碳弥散量(D)的比值能否在 COPD 患者中识别 PH,并预测其预后。
本研究纳入了 2010 年至 2017 年期间因住院治疗而入院的 937 例 COPD 患者,最终有 750 例患者可随访 5 年全因死亡率(研究人群 II)。记录了研究人群的临床特征。
与无 PH 的患者相比,有 PH 的 COPD 患者的 FVC/D 值更高。FVC/D 鉴别 COPD 患者 PH 的阈值为 0.44 l/mmol/min/kPa。多变量逻辑回归分析显示,FVC/D 是 COPD 患者 PH 的显著预测因子。研究人群 II 显示,合并 PH 组的 COPD 患者 5 年全因死亡率明显高于无 PH 组。与幸存者组相比,非幸存者组的 FVC/D 值显著升高。FVC/D 预测 5 年全因死亡率的阈值为 0.41 l/mmol/min/kPa。Kaplan-Meier 生存曲线显示,当 FVC/D 值≥0.41 l/mmol/min/kPa 时,COPD 患者 5 年累积生存率显著降低。多变量 cox 回归分析显示,FVC/D 是 COPD 患者 5 年全因死亡率的独立预后因素。
FVC/D 可在 COPD 患者中识别 PH,是 COPD 患者 5 年全因死亡率的独立预测因子。